Related Experiment Video
Updated: Apr 6, 2026

11:34
Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers
Published on: December 5, 2017
13.2K
Is "Polysomy" in Breast Carcinoma the "New Equivocal" in HER2 Testing?
1From the Calgary Laboratory Services and the Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, Canada.
American Journal of Clinical Pathology
|July 18, 2015
Abstract
No abstract available in PubMed .

